EP0701563A4 - Gen transfer zur behandlung von bindegewebe eines säugetierwirtes - Google Patents

Gen transfer zur behandlung von bindegewebe eines säugetierwirtes

Info

Publication number
EP0701563A4
EP0701563A4 EP94910861A EP94910861A EP0701563A4 EP 0701563 A4 EP0701563 A4 EP 0701563A4 EP 94910861 A EP94910861 A EP 94910861A EP 94910861 A EP94910861 A EP 94910861A EP 0701563 A4 EP0701563 A4 EP 0701563A4
Authority
EP
European Patent Office
Prior art keywords
mammalian host
connective tissue
product
gene encoding
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94910861A
Other languages
English (en)
French (fr)
Other versions
EP0701563A1 (de
Inventor
Joseph C Glorioso
Christopher H Evans
Paul D Robbins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pittsburgh
Original Assignee
University of Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pittsburgh filed Critical University of Pittsburgh
Publication of EP0701563A1 publication Critical patent/EP0701563A1/de
Publication of EP0701563A4 publication Critical patent/EP0701563A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • A01K2267/025—Animal producing cells or organs for transplantation
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP94910861A 1993-03-08 1994-03-07 Gen transfer zur behandlung von bindegewebe eines säugetierwirtes Withdrawn EP0701563A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2775093A 1993-03-08 1993-03-08
US27750 1993-03-08
PCT/US1994/002414 WO1994020517A1 (en) 1993-03-08 1994-03-07 Gene transfer for treating a connective tissue of a mammalian host

Publications (2)

Publication Number Publication Date
EP0701563A1 EP0701563A1 (de) 1996-03-20
EP0701563A4 true EP0701563A4 (de) 1997-07-02

Family

ID=21839568

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94910861A Withdrawn EP0701563A4 (de) 1993-03-08 1994-03-07 Gen transfer zur behandlung von bindegewebe eines säugetierwirtes

Country Status (4)

Country Link
EP (1) EP0701563A4 (de)
JP (1) JPH08511507A (de)
CA (1) CA2157782A1 (de)
WO (1) WO1994020517A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
US6858409B1 (en) 1988-05-27 2005-02-22 Amgen Inc. Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
US6159460A (en) * 1988-05-27 2000-12-12 Amgen Inc. Method for treating interleukin-1 mediated diseases
US6413511B1 (en) * 1990-12-20 2002-07-02 University Of Pittsburgh Of The Commonwealth System Of Higher Education Cartilage alterations by administering to joints chondrocytes comprising a heterologous polynucleotide
US5792751A (en) * 1992-04-13 1998-08-11 Baylor College Of Medicine Tranformation of cells associated with fluid spaces
EP0653943A4 (de) * 1992-07-13 1996-10-02 Baylor College Medicine Eine somatische gentherapie auf gelenke zielend.
AU1513495A (en) * 1993-12-14 1995-07-03 University Of Pittsburgh Systemic gene treatment of connective tissue diseases
US6239268B1 (en) 1994-09-09 2001-05-29 Neurocrine Biosciences, Inc. Interleukin-1 type 3 receptors
AU705595B2 (en) * 1994-09-09 1999-05-27 Neurocrine Biosciences, Incorporated Interleukin-1 type 3 receptors
ES2099029B1 (es) * 1994-12-29 1998-01-01 Boeheringer Ingelheim Espana S Empleo del plasmido pmamafgf para preparar farmacos vasorrelajantes y antihipertensivos.
US6281010B1 (en) 1995-06-05 2001-08-28 The Trustees Of The University Of Pennsylvania Adenovirus gene therapy vehicle and cell line
US5756283A (en) * 1995-06-05 1998-05-26 The Trustees Of The University Of Pennsylvania Method for improved production of recombinant adeno-associated viruses for gene therapy
US5866552A (en) * 1996-09-06 1999-02-02 The Trustees Of The University Of Pennsylvania Method for expressing a gene in the absence of an immune response
JP4771563B2 (ja) 1996-12-06 2011-09-14 アムジエン・インコーポレーテツド Ｉｌ−１媒介疾患を処置するためにｉｌ−１インヒビターを使用する組合せ療法
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
US6013253A (en) * 1997-08-15 2000-01-11 Amgen, Inc. Treatment of multiple sclerosis using consensus interferon and IL-1 receptor antagonist
JP2001514235A (ja) * 1997-09-02 2001-09-11 カイロン コーポレイション 遺伝子治療を利用して関節炎を処置するための組成物および方法
EP1939300A1 (de) 1999-05-28 2008-07-02 Targeted Genetics Corporation Verfahren und Zusammensetzung zur Senkung des Spiegels des Tumornekrosefaktors (TNF) bei TNF-assoziierten Leiden
JP2003501043A (ja) 1999-05-28 2003-01-14 ターゲティッド ジェネティクス コーポレイション 腫瘍壊死因子（ｔｎｆ）関連障害において、ｔｎｆのレベルを低下させるための方法および組成物
US8106098B2 (en) 1999-08-09 2012-01-31 The General Hospital Corporation Protein conjugates with a water-soluble biocompatible, biodegradable polymer
MXPA04000134A (es) 2001-06-26 2005-06-06 Abgenix Inc Anticuerpos para ligandos de osteoprotegerina.
BRPI0314038B8 (pt) 2002-09-06 2021-05-25 Amgen Inc anticorpo humano isolado, molécula de ácido nucleico isolada, vetor, uso de um anticorpo, e, composição farmacêutica
AR056806A1 (es) 2005-11-14 2007-10-24 Amgen Inc Moleculas quimericas de anticuerpo rankl- pth/ pthrp
US7833527B2 (en) 2006-10-02 2010-11-16 Amgen Inc. Methods of treating psoriasis using IL-17 Receptor A antibodies
US8323635B2 (en) 2007-11-14 2012-12-04 General Regeneratives, Ltd. Methods of using interleukin-1 receptor antagonist as a myeloprotective agent
TW201117824A (en) 2009-10-12 2011-06-01 Amgen Inc Use of IL-17 receptor a antigen binding proteins
CN101690801B (zh) 2009-10-26 2012-08-01 上海交通大学 白细胞介素-1受体拮抗剂的用途及其药物组合物
US20140234330A1 (en) 2011-07-22 2014-08-21 Amgen Inc. Il-17 receptor a is required for il-17c biology
WO2015087916A1 (ja) * 2013-12-12 2015-06-18 国立大学法人三重大学 ヒトｍｍｐ２を発現するトランスジェニック非ヒト哺乳類動物
US20160000936A1 (en) 2014-06-10 2016-01-07 Abbvie Inc. Biomarkers for inflammatory disease and methods of using same
US10041044B2 (en) 2016-07-29 2018-08-07 Trustees Of Boston University Age-associated clonal hematopoiesis accelerates cardio-metabolic disease development
EP3836954A1 (de) 2018-08-13 2021-06-23 Iltoo Pharma Kombination von interleukin-2 mit einem interleukin-1-inhibitor, konjugate und therapeutische verwendungen davon
WO2022081776A1 (en) 2020-10-13 2022-04-21 Kriya Therapeutics, Inc. Viral vector constructs for delivery of nucleic acids encoding cytokines and uses thereof for treating cancer
WO2023222565A1 (en) 2022-05-16 2023-11-23 Institut National de la Santé et de la Recherche Médicale Methods for assessing the exhaustion of hematopoietic stems cells induced by chronic inflammation

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0176170A1 (de) * 1984-06-04 1986-04-02 Pasteur Merieux Serums Et Vaccins Herpes simplex-Virus als Vektor
WO1992007943A1 (en) * 1990-10-31 1992-05-14 Somatix Therapy Corporation Retroviral vectors useful for gene therapy
WO1992011359A1 (en) * 1990-12-20 1992-07-09 University Of Pittsburgh Of The Commonwealth System Of Higher Education A truncated interleukin-1 receptor gene for the treatment of arthritis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5319071A (en) * 1987-11-25 1994-06-07 Immunex Corporation Soluble interleukin-1 receptors
US5180182A (en) * 1991-08-26 1993-01-19 Haworth James R Trailer hitch alignment device

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0176170A1 (de) * 1984-06-04 1986-04-02 Pasteur Merieux Serums Et Vaccins Herpes simplex-Virus als Vektor
WO1992007943A1 (en) * 1990-10-31 1992-05-14 Somatix Therapy Corporation Retroviral vectors useful for gene therapy
WO1992011359A1 (en) * 1990-12-20 1992-07-09 University Of Pittsburgh Of The Commonwealth System Of Higher Education A truncated interleukin-1 receptor gene for the treatment of arthritis

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
BANDARA, G. ET AL: "Gene transfer to synoviocytes: prospects for gene treatment of arthritis", DNA CELL BIOL. (1992), 11(3), 227-31 CODEN: DCEBE8;ISSN: 1044-5498, 1992, XP000671125 *
BANDARA, G. ET AL: "Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer", PROC. NATL. ACAD. SCI. U. S. A. (1993), 90(22), 10764-8 CODEN: PNASA6;ISSN: 0027-8424, 1993, XP002029933 *
BLAKE J. ROESSLER ET AL.: "Adenoviral-mediated gene transfer to rabbit synovium in vivo", THE JOURNAL OF CLINICAL INVESTIGATION, vol. 92, no. 2, August 1993 (1993-08-01), pages 1085 - 1092, XP000671409 *
EVANS C H ET AL.: "Gene transfer to joints for arthritis therapy", JOURNAL OF CELLULAR BIOCHEMISTRY, vol. 16, no. F, April 1992 (1992-04-01), pages 46, XP000566580 *
EVANS C H ET AL: "SYNOVIAL CELL TRANSPLANTS FOR GENE TRANSFER TO JOINTS.", FIRST INTERNATIONAL CONGRESS OF THE CELL TRANSPLANT SOCIETY, PITTSBURGH, PENNSYLVANIA, USA, MAY 31-JUNE 3, 1992. TRANSPLANT PROC 24 (6). 1992. 2966. CODEN: TRPPA8 ISSN: 0041-1345, XP000577114 *
G. BANDARA ET AL.: "Intraarticular expression of IRAP by gene transfer", ARTHRITIS AND RHEUMATISM, vol. 35, no. 9, September 1992 (1992-09-01), pages S193, XP000563856 *
HUNG, G.L. ET AL: "Suppression of intra-articular responses to interleukin-1 by transfer of the interleukin-1 receptor antagonist gene to synovium", GENE THER. (1994), 1(1), 64-9 CODEN: GETHEC, 1994, XP000671119 *
PAUL D. ROBBINS ET AL.: "Retroviral vectors for use in human gene therapy for cancer, Gaucher disease, and arthritis", ANNAL NEW YORK ACADEMY OF SCIENCES, vol. 716, June 1993 (1993-06-01), pages 26 - 29, XP000565748 *
See also references of WO9420517A1 *
XIANG GAO ET AL.: "A novel cationic liposome reagent for efficient transfection of mammalian cells", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 179, no. 1, 30 August 1991 (1991-08-30), ORLANDO, FL US, pages 280 - 285, XP000572654 *

Also Published As

Publication number Publication date
WO1994020517A1 (en) 1994-09-15
CA2157782A1 (en) 1994-09-15
EP0701563A1 (de) 1996-03-20
JPH08511507A (ja) 1996-12-03

Similar Documents

Publication Publication Date Title
EP0701563A4 (de) Gen transfer zur behandlung von bindegewebe eines säugetierwirtes
WO2002032962A3 (en) Compositions of human proteins and method of use thereof
EP1005540A4 (de) Ikk-beta proteines, nukleinsäuren und verfahren
EP2258722A3 (de) Antikörper gegen Fibroblasten Wachstumsfaktor-ähnliche Polypeptide
EP1798239A3 (de) G-Protein-gekoppelte Rezeptoren und deren Verwendung
WO2001072976A3 (en) 32142, 21481, 25964, 21686, novel human dehydrogenase molecules and uses therefor
WO1999033982A3 (en) Human genes and gene expression products i
DE69632536D1 (de) Impfstoffe für das respiratorische-synzytial-virus mit nuklein säuren
WO2000027994A3 (en) Chlamydia pneumoniae genome sequence
WO2001062794A3 (en) 18607, a human calcium channel
EP1439230A3 (de) Menschliche transmembranprotein TMP-2 gen
AU2001278797A1 (en) Expression vector using for animal cell
EP1053245A4 (de) 45 menschliche sekretierte proteine
IL122206A0 (en) Adeno-associated virus vectors for gene expression
WO1997003192A3 (en) Chromosome 1 gene and gene products related to alzheimer's disease
EP1281717A3 (de) Mutmasslicher Ionenkanal
WO2000017222A8 (en) 31 human secreted proteins
WO1998011221A3 (en) CAR, a novel coxsackievirus and adenovirus receptor
EP0744408A3 (de) Das ob Protein der Rhesusaffen und seine DNA
WO2000077239A3 (en) Novel genes encoding proteins having diagnostic, preventive, therapeutic, and other uses
CA2336261A1 (en) Cyclin e2 genes and proteins
WO2000008157A3 (en) Human anion transporter genes atnov
WO2000061774A3 (en) Bone morphogenic proteins
EP0805204A3 (de) Nebenhoden-spezifisches Rezeptorprotein und dessen Verwendung
GB9622174D0 (en) Gene expression

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19951006

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RIN1 Information on inventor provided before grant (corrected)

Inventor name: ROBBINS, PAUL, D.

Inventor name: EVANS, CHRISTOPHER, H.

Inventor name: GLORIOSO, JOSEPH, C.

RHK1 Main classification (correction)

Ipc: C12N 15/86

A4 Supplementary search report drawn up and despatched

Effective date: 19970521

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20010509

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030319